| 摘要: |
| 《药品生产质量管理规范(2010年修订)》已颁布实施5年,但从2015年度认证检查情况看,部分企业的生产质量管理仍存在薄弱环节。本文通过对2015年度的检查缺陷项目的汇总分析,并与2014年度的检查情况进行对比,供业内掌握药品生产企业仍存在的突出问题;同时提出改进建议。 |
| 关键词: GMP认证 缺陷项目 分析 建议 |
| DOI:10.13506/j.cnki.jpr.2016.07.018 |
| 基金项目: |
|
|
|
| Analysis on the situation of drug GMP certification inspection for Shandong Province in 2015 |
| HAN Ying,BAI Jianxue,XU Dan,CAO Hongyan,HU Jingfeng,CHAI Fayong |
| (Center for Evaluation and Certification,SDFDA, Jinan 250014,China) |
| Abstract: |
| Good Manufacturing Practice (Revised 2010) had been formally promulgated and implemented for five years. However, there were still various weakness for certain pharmaceutical enterprises in the production quality management from the analysis on the situation of the certification inspection in 2015.This paper aimed to discover the outstanding problems existing in pharmaceutical production enterprises for the industry through the comparative analysis of the annual inspection defect items in 2015 and 2014. At the same time, this paper also provided improvement suggestion for pharmaceutical enterprises. |
| Key words: GMP certification Defective items Analysis Suggestion |